Day: July 27, 2021
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present clinical and pre-clinical data, including updated analyses from the Phase 2 STRIVE study and an in vitro evaluation of rezafungin activity against Candida and Aspergillus spp. isolates collected in Asia-Pacific countries, in two presentations at the International Society for Human and Animal Mycology (ISHAM) Asia Congress taking place virtually from August 6-8, 2021.
Rezafungin is a novel once-weekly echinocandin currently being studied in Phase 3 trials for the treatment and prevention of serious fungal infections in critically ill patients. ISHAM Asia...
City of Walla Walla, Washington Orders Beam Global EV ARC™ Off-Grid EV Charging System
Written by Customer Service on . Posted in Public Companies.
Rapidly deployed sustainable EV charging infrastructure to kick off fleet electrification initiative
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable technology for electric vehicle (EV) charging, outdoor media and energy security, announced that the City of Walla Walla in Washington State has ordered its first EV ARC™ solar-powered EV charging system to power two fully electric city fleet vehicles. The system also serves the City’s emergency preparedness and energy resiliency programs.
Walla Walla’s EV ARC™ is equipped with a ChargePoint Dual Port charger and an emergency power panel. The EV ARC™ generates and stores its own electricity and delivers that electricity to power City fleet EVs and first responders, day or night, and during inclement weather...
Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
Written by Customer Service on . Posted in Public Companies.
BOSTON, July 27, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 3, 2021 to report its second quarter 2021 financial results and provide a corporate update.
To access the live conference call, please dial (844) 498-0570 (domestic) or (409) 983-9726 (international), and refer to conference ID 6776764. A webcast of the call will also be available under “Events & Presentations” in the Investor Relations section of the Rhythm website at ir.rhythmtx.com. The archived webcast will be available on Rhythm’s website approximately two hours after the conference call and will be available...
Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021
Written by Customer Service on . Posted in Public Companies.
Management to host conference call and webcast at 8:30 AM ET on that day
NEVE ILAN, Israel, July 27, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces that it will release its second quarter 2021 financial and operating results for the period ended June 30, 2021 on Tuesday, August 10, 2021 prior to the start of trading. Management will host a conference call and webcast at 8:30am ET on that day.
Conference call and webcast details Tuesday, August 10, 2021 @ 8:30am ETInvestor domestic dial-in: 855-327-6837Investor international dial-in: 631-891-4304Conference ID: 10015901Webcast link: http://public.viavid.com/index.php?id=146006
About Nanox:
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is...
StepStone Group to Announce First Quarter Fiscal 2022 Results on August 10, 2021
Written by Customer Service on . Posted in Public Companies.
NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP) today announced that the Company will release its results for the quarter ending June 30, 2021 after the market closes on Tuesday, August 10, 2021. This represents results for the first quarter of the fiscal year ending March 31, 2022.
Webcast and Earnings Conference Call
Management will host a webcast and conference call on Tuesday, August 10, 2021 at 5:00 pm ET to discuss the Company’s results for the first quarter of the fiscal year ending March 31, 2022. The conference call will also be made available in the Shareholders section of the Company’s website at https://shareholders.stepstonegroup.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register.
The conference call can...
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
Written by Customer Service on . Posted in Public Companies.
ROCHESTER, Mich., July 27, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, August 4, 2021, at 4:30 p.m. Eastern time to discuss its results for the second quarter, ended June 30, 2021. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question and answer period.
Conference Call Information:Date:
Wednesday, August 4, 2021Time:
4:30 p.m. Eastern time (1:30 p.m. Pacific time)Webcast:
http://public.viavid.com/index.php?id=146009Toll Free Number:
800-430-8332International Number:
323-289-6576Conference ID:
2901587Please call the conference telephone number or log on to...
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Católica de Chile
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, July 27, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned subsidiary, Altum Pharmaceuticals Inc. (“Altum”), and Pontificia Universidad Católica de Chile have obtained approval from the Instituto de Salud Publica de Chile to conduct their planned randomized placebo-controlled trial (“IN2COVID”) in COVID-19 patients. The trial, set to start in early August, tests BetterLife’s proprietary inhaled interferon alpha-2b (“IFN-a2b”) product, AP-003.
BetterLife’s Chief Executive Officer, Dr. Ahmad Doroudian, commented, “We are excited to initiate this trial of AP-003 in COVID-19 patients in collaboration with the Escuela de Medicina (school of medicine) at Pontificia Universidad Católica de Chile....
Moving iMage Technologies’ Frank Tees Named President of International Cinema Technology Association (ICTA)
Written by Customer Service on . Posted in Public Companies.
Frank TeesMoving iMage Technologies’ Frank Tees named President of International Cinema Technology Association (ICTA)FOUNTAIN VALLEY, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Moving iMage Technologies (NYSE: MITQ) (“MiT”), a leading digital cinema company that designs, manufactures, integrates, installs and distributes a full suite of proprietary and custom-designed equipment, announced today that Frank Tees, MiT’s Vice President, Technical Sales Support, has been named President of the International Cinema Technology Association (ICTA), the cinema industry’s trade association whose members are widely recognized as the experts within the industry on theatre equipment and services.
Tees will continue in his position at MiT. He had served as a Vice President of ICTA for the past three years and has served on...
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
Written by Customer Service on . Posted in Public Companies.
ROCKAWAY, NJ, July 27, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,065,444 to electroCore, relating to the use of a mobile phone for stimulating the trigeminal nerve to treat disorders.
The newly issued patent includes descriptions of devices and methods that allow a patient to self-treat a medical condition, such as migraine headache, by non-invasive electrical stimulation of nerves of the head, particularly supraorbital, supratrochlear, infraorbital, and mental nerves in the vicinity of their foramen or notch. The system comprises a handheld mobile device, such as a smartphone, that is applied to the surface of the patient’s head. One or more electrodes...
CoreCivic Announces 2021 Second Quarter Earnings Release and Conference Call Dates
Written by Customer Service on . Posted in Public Companies.
BRENTWOOD, Tenn., July 27, 2021 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today that it will release its 2021 second quarter financial results after the market closes on Monday, August 9, 2021.
A live broadcast of CoreCivic’s conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Tuesday, August 10, 2021, and will be accessible through the Company’s website at www.corecivic.com under the “Events & Presentations” section of the “Investors” page. The live broadcast can also be accessed by dialing 800-353-6461 in the U.S. and Canada, including the confirmation passcode 7244786. An online replay of the call will be archived on our website promptly following the conference call. In addition, there will be a telephonic replay available beginning at...